Back to search

Article

Does the Metabolic Syndrome and Its Components Have Prognostic Significance for Renal and Cardiovascular Outcomes in IgA Nephropathy?

2024-04-15

Abstract excerpt

<h4>Background: </h4> Cardiovascular (CV) morbidity and mortality are many times higher in chronic kidney disease (CKD), as well as IgA nephropathy (IgAN), than in the general population. The occurrence of metabolic syndrome (MetS) and metabolic risk factors are independent risk factors for CV disease and renal progression. The study aimed to determine the prognostic role of metabolic profiles in a homogenous grou...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2a4a81bd-1439-5d8d-a5a6-ff8cfe4981b5
DOI
10.20944/preprints202404.0980.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Does the Metabolic Syndrome and Its Components Have Prognostic Significance for Renal and Cardiovascular Outcomes in IgA Nephropathy?DOI 10.20944/preprints202404.0980.v1
A high triglyceride to high-density lipoprotein cholesterol ratio is associated with poor renal outcome in IgA nephropathy patientsSemantic proximity
Association of Cardiometabolic Index with Mortality Risk in Early-Stage Cardiovascular-Kidney-Metabolic Syndrome and Its Potential Role in Metabolically Unhealthy Phenotypes: Evidence from NHANES 2007-2018.Semantic proximity
Left ventricular myocardial mass index associated with cardiovascular and renal prognosis in IgA nephropathySemantic proximity
High Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome Among US Adults From 1999-2020 - An analysis of the NHANES surveySemantic proximity
Metabolic syndrome in haemodialysis patients: Prevalence, determinants and association to cardiovascular outcomesSemantic proximity
Lipoprotein(a) and Cardiovascular-Kidney-Metabolic Syndrome: Stage-Specific Associations With All-Cause Mortality and Major Adverse Cardiovascular Events in the UK BiobankSemantic proximity
Cardiovascular-Kidney-Metabolic Multimorbidity Burden and Phenotype Differentially Influence Cardiovascular and Renal Risk in Advanced Chronic Kidney Disease.Semantic proximity
Association of non-invasive liver-related scores with cardiovascular disease and a four-domain cardiovascular-renal-hepatic-metabolic phenotype in patients with type 2 diabetes mellitus and MASLD.Semantic proximity
Regional Prevalence, Stage Distribution, and Temporal Trends of Cardiovascular-Kidney-Metabolic Syndrome in the Americas, Europe and Western Pacific: A Systematic Review and Meta-AnalysisSemantic proximity
Cardiometabolic Risk Phenotypes and Chronic Kidney Disease Incidence in Older Adults：A Nationwide Longitudinal Cohort StudySemantic proximity
Molecular mechanisms of disorders of lipid metabolism in chronic kidney disease.Semantic proximity
Association of the uric acid-to-HDL cholesterol ratio with cardiorenal syndrome: a two-stage study with external validation and exploratory pathway analysisSemantic proximity
Select a neighboring publication to make it the new centre.